Sector Expert: Josh Jennings

Cowen & Co.



Recent Quotes

"We initiate with an Outperform on VIVE."

— Josh Jennings, Cowen & Co. (5/3/17)
more >

"JNJ has sustained market leadership in 85% of platforms."

— Josh Jennings, Cowen & Co. (1/23/13)
more >

"JNJ had two positive phase 3 study results for canagliflozin."

— Josh Jennings, Cowen & Co. (10/2/12)
more >

"With renal denervation a potential game changer, MDT remains our top pick for 2012."

— Josh Jennings, Cowen & Co. (3/12/12)
more >



Due to permission requirements, not all quotes are shown.